|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||23.74 - 25.22|
|52 Week Range||23.28 - 45.44|
|Beta (5Y Monthly)||2.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||53.33|
Insmed (INSM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Insmed (INSM) delivered earnings and revenue surprises of 2.20% and 1.09%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Performance at Insmed Incorporated ( NASDAQ:INSM ) has been reasonably good and CEO Will Lewis has done a decent job of...